期刊文献+

肿瘤生物合成的异常及其临床应用 被引量:4

Biosynthetic alteration in cancer and its clinical application
原文传递
导出
摘要 肿瘤的发生过程中,除了能量代谢外,肿瘤的生物合成代谢与人体正常组织也有很大不同,具体表现在核苷酸、脂质和蛋白质的生物合成这3个方面。肿瘤细胞的生物合成能力明显强于正常细胞,但它的合成途径和方式又不同于正常细胞,其主要以从头合成为主,明显强于正常细胞,且这种生物合成能力的增强往往是以牺牲机体其他细胞为代价的。对肿瘤不同的生物合成途径的研究既是挑战也是机遇,弄清肿瘤细胞生物合成的机制,对肿瘤早期诊断和靶向治疗具有重要的意义。 Besides energy metabolism, biosynthesis of cancer cells, such as nucleotide, lipid and protein synthesis, is also different from normal cells. The biosynthesis is more active in cancer cells than in normal cells, and the synthetic pathways and processes in cancer cells are also different from normal cells. The cancer cells prefer to de novo synthesis, which is more active in cancer cells than in normal cells. The active biosynthesis of cancer cells is at the expense of other normal cells in body. The study of altered biosynthesis in cancer is challenging but creates an opportunity. Further understanding of biosynthesis mechanism in cancer cells may lead to a new approach in early diagnosis and target therapy of cancer.
作者 郑杰
出处 《肿瘤》 CAS CSCD 北大核心 2012年第1期74-78,共5页 Tumor
关键词 肿瘤 生物合成通路 核酸类 脂质代谢 蛋白质 Neoplasms Biosynthetic pathways Nucleic acids Lipid metabolism Protein
  • 相关文献

参考文献28

  • 1HENGSTSCHI.AGER M, MUDRAK I, WINTERSBERGER E, et al. A common regulation of genes encoding enzymes of the deoxynucleotide metabolism is lost after neoplastic transformation[J]. Cell Growth Differ, 1994, 5(12): 1389-1394.
  • 2KIDD E A, YU J, LI X, et al. Variance in the expression of 5-fluorouracil pathway genes in colorectal cancer[J]. Clin Cancer Res, 2005, 11(7): 2612-2619.
  • 3TAKEZAWA K, OKAMOTO I, TSUKIOKA S, et al. Identification of thymidylate synthase as a potential therapeutic target for lung cancer[J]. Br J Cancer, 2010, 103(3): 354-361.
  • 4JIANG P, DU W, WANG X, et al. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase[J]. Nat Cell Biol, 2011, 13(3):310-316.
  • 5AMEMIYA-KUDO M, SHIMANO H, HASTY A H, et al. Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes[J]. J Lipid Res. 2002.43(8): 1220-1235.
  • 6MASHIMA T, SEIMIYA H, TSURUO T. De novo fatty- acid synthesis and related pathways as molecular targets for cancer therapy[J]. BrJ Cancer, 2009, 100(9): 1369-1372.
  • 7FLAVIN R, PELUSO S, NGUYEN P L, et al. Fatty acid synthase as a potential therapeutic target in cancer[J]. Future Oncol, 2010, 6(4):551-562.
  • 8LIU H, LIU J Y, WU X, et al. Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/ prognosis marker[J]. Int J Biochem Mol Biol, 2010, 1 (1): 69-89.
  • 9KROEMER G, POUYSSEGUR J. Tumor cell metabolism: cancer' s Achilles' heel[J]. Cancer Cell, 2008, 13(6): 472-482.
  • 10CAI L, SUTTER B M, LI B, et al. Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes[J]. Mol Cell, 2011,42(4): 426-437.

同被引文献40

  • 1程媛,尚靖,张陆勇.脂毒性与非酒精性脂肪肝的研究进展[J].华西医学,2008,23(6):1482-1484. 被引量:5
  • 2黄劲,宋文忠,何作祥.恶性肿瘤细胞葡萄糖转运蛋白与脱氧葡萄糖摄取[J].中华核医学杂志,2006,26(3):190-192. 被引量:13
  • 3DEBERARDINIS RJf LUM J J, HATZIVASSILIOU C, et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation[J].Cell Me tab,2008,7(1):11-20.
  • 4MENENDEZ J A, LUPU R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis[j]. Nat Rev Cancer, 2007, 7(10):763-777.
  • 5ENOCH H C, CATALA A, STRITTMATTER P. Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipidU]. J Biol Chem, 1 976, 251(16):5095-5103.
  • 6ZHANG L, GE L, PARIMOO S, et al. Human stearoyl-CoA desaturase: alternative transcripts generated from a single gene by usage of tandem polyadenylation sites[J]. Biochem J,1999,340 (Pt 1):255-264.
  • 7WANGJ, YU L, SCHMIDT R E, et al. Characterization of HSCD5, a novel human stearoyl-CoA desaturase unique to primates[J]. Biochem Biophys Res Commun, 2005, 332(3):735-742.
  • 8FALVELLA F S, PASCALE R M, GARIBOLDI M, et al. Stearoyl-CoA desaturase 1 (Scd 1) gene overexpression is associated with genetic predisposition to hep at oca rci nogenesis in mice and ratsL)]. Carcinogenesis, 2002, 23(1 1):1933-1936.
  • 9GRIFFITTS J, TESIRAM Y, REID G E, et al. In vivo MRS assessment of altered fatty acyl unsaturation in liver tumor formation of a TGF alpha/c-myc transgenic mouse modelU]. J Lipid Res, 2009, 50(4):611-622.
  • 10LI J, DING S F, HABIB N A, et al. Partial characterization of a cDNA for human stearoyl-CoA desaturase and changes in its mRNA expression in some normal and malignant tissuestl]. Int J Cancer, 1994, 57(3):348-352.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部